Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial

New dengue vaccines are needed to prevent this globally expanding vector-borne disease. The V180 vaccine candidate consists of four recombinant, soluble, dengue virus envelope glycoproteins and has been previously evaluated in two clinical trials for safety and immunogenicity in Flavivirus-naive par...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Trop Med Hyg
Asıl Yazarlar: Durbin, Anna P., Pierce, Kristen K., Kirkpatrick, Beth D., Grier, Palmtama, Sabundayo, Beulah P., He, Helen, Sausser, Michele, Russell, Amy Falk, Martin, Jason, Hyatt, Donna, Cook, Melissa, Sachs, Jeffrey R., Lee, Andrew Wen-Tseng, Wang, Liman, Coller, Beth-Ann, Whitehead, Stephen S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society of Tropical Medicine and Hygiene 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7410446/
https://ncbi.nlm.nih.gov/pubmed/32394880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.20-0042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller